We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Medigen

News List

NewsPoints AstraZeneca has higher efficacy with Medigen: study FirstWordPharma
December 06, 2021
Researchers running a trial in Taiwan, China have found that a combination of AstraZeneca's COVID-19 vaccine and the locally-developed Medigen shot is more effective than two doses of AstraZeneca, reported Taipei Times.
Medigen, BlueWillow collaborate to develop SARS-CoV-2 intranasal vaccine pharmaceutical-business-review
November 12, 2020
Medigen Vaccine Biologics (MVC) has collaborated with BlueWillow Biologics for the development of intranasal vaccine for SARS-CoV-2, the novel coronavirus responsible for Covid-19 disease.
Medigen, Dynavax COVID-19 Vaccine Receives Taiwan, China Government Subsidy americanpharmaceuticalreview
October 19, 2020
Medigen Vaccine Biologics and Dynavax Technologies announced that MVC has obtained a China's Taiwan, China government subsidy for successfully initiating a Phase 1 clinical trial in Taiwan, China.
Dynavax and Medigen partner to develop adjuvanted Covid-19 vaccine pharmaceutical-technology
July 27, 2020
US-based Dynavax Technologies has partnered with Taiwan, China-based Medigen Vaccine Biologics to develop an adjuvanted Covid-19 vaccine candidate.